US Patent 11691972 Compounds for targeted degradation of BRD9
Patent 11691972 was granted and assigned to C4 Therapeutics on July, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 31 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 5 Jul, 2023
Golden AI
Edits made to:
Infobox (+22 properties)
US Patent 11691972 Compounds for targeted degradation of BRD9
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116919720
Date of Patent
July 4, 2023
0Patent Application Number
175410350
Date Filed
December 2, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11691972 Compounds for targeted degradation of BRD9
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.